Business in Shanghai hits resumption mode
chinadaily.com.cn
news
2022-06-02 00:00:00

By HE WEI in Shanghai | China Daily | Updated: 2022-06-02 09:29 Shanghai's Zhangjiang Pharmaceutical Valley. [Photo/VCG] Domestic and international companies based in Shanghai are going full steam ahead to resume operations after the two-month disruption to business caused by COVID-related lockdowns. They have lined up new investments and novel products to indicate their confidence in China. Laekna Therapeutics, a biotechnology company in Shanghai's Zhangjiang Pharmaceutical Valley, has completed dosing the first patients in the United States and China in a phase III clinical trial for breast cancer treatment, in spite of normal operations getting disrupted by the sudden COVID flare-ups in this spring.
